| Hillard C. Endocannabinoids and Vascular Function. The Journal
of Pharmacology and Experimental Therapeutics 2000; 294: 27-32. Hubbard J, Franco S, Onaivi E. Marijuana: Medical Implications. American
Family Physician 1999; 60: 2583-2588. http://www.aafp.org/afp/991201ap/2583.html
Straus S. Immunoactive cannabinoids: Therapeutic prospects for
marijuana constituents. PNAS 2000;97: 9363-9364.
White D, Martin D, Geller T, Pittman T. Stroke associated with
marijuana abuse. Pediatric Neurosurgery 2000; 32: 92-94.
Marmor J. Medical Marijuana. West J Med 1998; 168:
540-543.
Clark P. The Ethics of Medical Marijuana: Government Restrictions vs.
Medical Necessity. Journal of Public Health Policy 2000; 21(1):
40-60.
Izzo A, Mascolo N, Capasso F. Marijuana in the new millennium:
perspectives for cannabinoid research. Trends-Pharmacol-Sci. 2000;
21(8): 281-2.
Schwartz R, Voth E, Sherida M. Marijuana to Prevent Nausea and Vomiting
in Cancer Patients: A Survey of Clinical Oncologists 1997; 90(2): 167-172.
Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner J. Cardiovascular
effects of endocannabinoids-the plot thickens. Prostaglandins and Other
Lipid Mediators 2000; 61: 71-84.
Hollister L. Marijuana and immunity. Journal of Psychoactive
Drugs 1988; 20(1): 3-8.
Noyes, R., Jr.; Brunk, S.F.; Baram, D.A.; and Canter, A. Analgesic effect of
delta-9-tetrahydrocannabinol. J Clin Pharmacol 15(2-3):139-143,
February-March, 1975a.
Noyes, R., Jr.; Brunk, S.F.; Avery, D.A.H.; and Canter, A.C. The analgesic
properties of delta-9-tetrahydrocannabinol. Clin Pharmacol Ther
18(1):84-89, July, 1975b.
Raft, D.; Gregg, J.; Ghia, J.; and Harris, L. Effects of intravenous
tetrahydrocannabinol on experimental and surgical pain. Clin Pharmacol Ther
21(1):26-33, 1977.
Sallan, S.E.; Zinberg, N.E.; and Frei, III, E. Antiemetic effect of
delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N
Engl J Med 293:795-797, 1975.
Sallan, S.E.; Cronin, C.; Zelen, M.; and Zinberg, N.E. Antiemetics in
patients receiving chemotherapy for cancer--a randomized comparison of
delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med
302:135-138, 1980.
Levitt, M.; Faiman, C.; Hawks, R.; and Wilson, A. Randomized double-blind
comparison of delta-9-tetrahydrocannabinol (THC) and marijuana as chemotherapy
antiemetics. Proc Am Soc Clin Oncol 3:91, 1984.
American Academy of Ophthalmology. "The Use of Marijuana in the
Treatment of Glaucoma." Statement by the Board of Directors of the American
Academy of Ophthalmology, PO Box 7424, San Francisco, CA, June 1992.
Hepler, R.S., and Frank, I.R. Marijuana smoking and intraocular pressure.
(Letter). JAMA 217:1392, 1971.
Hepler, R.S., and Petrus, R.J. Experiences with administration of marihuana
to glaucoma patients. In: Cohen, S., and Stillman, R.C., eds. The
Therapeutic Potential of Marihuana. New York: Plenum Medical Books, 1976.
pp. 63-75.
Beal, J.E.; Olson, D.O.; Laubenstein, L.; et al. Dronabinol as a treatment
for anorexia associated with weight loss in patients with AIDS. J Pain
Symptom Manage 10:89-97, 1995.
Farrow, J.A.; Rees, J.M.; and Worthington-Roberts, B.S. Health,
developmental, and nutritional status of adolescent alcohol and marijuana
abusers. Pediatrics 79:218, 1987.
Foltin, R.W.; Brady, J.V.; and Fischman, M.W. Pharmacol Biochem Behav
25:577-582, 1986.
Foltin, R.W.; Fischman, M.W.; and Byrne, M.F. Effects of smoked marijuana on
food intake and body weight of humans living in a residential laboratory. Appetite
11:1-14, 1988.
Gorter, R.; Seifried, M.; and Volberding, P. Dronabinol effects on weight in
patients with HIV infection. AIDS 6:127, 1992.
Greenberg, I.; Kuehnle, J.; Mendelson, J.H.; and Bernstein, J.G. Effects of
marijuana use on body weight and caloric intake in humans. Psychopharmacology
49:79-84, 1976.
Haines, L., and Green, W. Marijuana use patterns. Br J Addict
65:347, 1970.
Hoover, D.R.; Saah, A.J.; Bacellar, H.; et al. Clinical manifestations of
AIDS in the era of Pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N
Engl J Med 329:1922-1929, 1993.
Kaslow, R.A.; Blackwelder, W.C.; Ostrow, D.G.; et al. No evidence for a role
of alcohol or other psychoactive drugs in accelerating immunodeficiency in
HIV-1-positive individuals: A report from the Multicenter AIDS Cohort Study. JAMA
26:3424-3429, 1989.
Kotler, D.P.; Tierney, P.R.; Wang, J.; and Pierson, R.N., Jr. The magnitude
of body cell mass depletion determines the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447, 1989.
MacCallan, D.C.; Noble, C.; Baldwin, C.; et al. Energy expenditure and
wasting in human immunodeficiency virus infection. N Engl J Med
333:83-88, 1995.
Mulligan, K.; Grunfeld, C.; Hellerstein, M.K.; et al. Anabolic effects of
recombinant human growth hormone in patients with wasting associated with human
immunodeficiency virus infection. J Clin Endocrinol Metab 77:956-962,
1993.
Nelson, K.; Walsh, D.; Deeter, P.; and Sheehan, F. A phase II study of
delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated
anorexia (Review). J Palliat Care 10(1):14-18, Spring 1994.
Oster, M.H.; Enders, S.R.; Samuels, S.J.; Cone, L.A.; et al. Megestrol
acetate in patients with AIDS and cachexia. Ann Intern Med 121:400-408,
1994.
Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane, M.; Shepard, K.V.; and
Wadleigh, R.G. Recent clinical experience with dronabinol. Pharmacol Biochem
Behav 40:695-700, 1991.
Tart, C.T. Marijuana intoxication: Common experiences. Nature
226:701, 1970.
VonRoenn, J.; Armstrong, D.A.; Kotler, D.P.; et al. Megestrol acetate in
patients with AIDS-related cachexia. Ann Intern Med 121:393-399, 1994.
Williams, E.G.; Himmelsbach, C.K.; Wikler, A.; and Rudle, D.C. Studies on
marihuana and pyrahexyl compound. Publ Health Rep 61(29):1059, July 19,
1946.
Workshop on the Medical Utility of Marijuana. National Institutes of
Health. http://www.nih.gov/news/medmarijuana/MedicalMarijuana.htm
Marijuana. Drug Enforcement Administration.
http://www.usdoj.gov/dea/concern/marijuana.htm
Abrams, D.I.; Hilton, J.F.; et al. Short-Term Effects of Cannabinoids
in Patients with HIV-1 Infection. Ann Intern Med.
2003;139:258-266. Wilson. D.M.; Peart, J.; et al. Physiochemical and
pharmacological characterization of a j-THC aerosol generated by a metered dose
inhaler. Drug and Alcohol Dependence 67:259-267, 2002. Blazquez,
C; Gonzalez-Feria, L; et al. Cannabinoids inhibit the vascular endothelial
growth factor pathway in gliomas. Cancer Res. 2004 Aug 15;64(16):5617-23.
|
